Literature DB >> 7389273

Plasma alpha 2HS-glycoprotein concentration in Paget's disease of bone: its possible significance.

B A Ashton, R Smith.   

Abstract

1. The plasma concentration of the alpha 2HS-glycoprotein has been measured in 58 normal adults and in patients with Paget's disease of bone before (24) and during treatment (16). 2. The average plasma alpha 2HS-glycoprotein was lower in the patients with Paget's disease than in the normal adults and was inversely related to plasma alkaline phosphatase activity (r = -0.55, n = 24, P less than 0.001). 3. When the patients with Paget's disease were treated with either diphosphonate or calcitonin, the plasma alpha 2HS-glycoprotein concentration increased towards normal. In those patients treated with calcitonin, this increase was too rapid to be entirely accounted for by a cessation of bone formation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389273     DOI: 10.1042/cs0580435

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  Fetuin: an acute phase protein in cattle.

Authors:  K M Dziegielewska; W M Brown; C C Gould; N Matthews; J E Sedgwick; N R Saunders
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

2.  Immunohistochemical localization of alpha 2HS glycoprotein in dentin.

Authors:  Y Takagi; H Shimokawa; M Suzuki; H Nagai; S Sasaki
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

3.  A fetuin-related glycoprotein (alpha 2HS) in human embryonic and fetal development.

Authors:  K M Dziegielewska; K Møllgård; M L Reynolds; N R Saunders
Journal:  Cell Tissue Res       Date:  1987-04       Impact factor: 5.249

4.  Decreased levels of alpha 2 HS-glycoprotein in children with protein-energy-malnutrition.

Authors:  P O Abiodun; J C Ihongbe; F Dati
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

5.  Three forms of BRP-2 (bone resorptive proteins) from human cancer ascites fluid and their relationship to human serum alpha-2 HS-glycoprotein.

Authors:  M S Lamkin; C Colclasure; M Rodrick; R F Troxler; G D Offner; W S Lloyd; K Schmid; R B Nimberg
Journal:  Calcif Tissue Int       Date:  1987-09       Impact factor: 4.333

6.  Human fetuin/alpha 2 HS glycoprotein in colloid and parenchymal cells in human fetal pituitary gland.

Authors:  F A von Bülow; M S Janas; O B Terkelsen; K Møllgård
Journal:  Histochemistry       Date:  1993-01

7.  Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript.

Authors:  C C Lee; B H Bowman; F M Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study.

Authors:  L Kalabay; K Cseh; S Benedek; S Fekete; T Masszi; K Herjeczki; T Pozsonyi; L Jakab; L Jakab
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

9.  Noncollagenous proteins in normal and pathological human bone.

Authors:  K J Quelch; W G Cole; R A Melick
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

10.  Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study.

Authors:  Joachim H Ix; Christina L Wassel; Douglas C Bauer; Damon Toroian; Frances A Tylavsky; Jane A Cauley; Tamara B Harris; Paul A Price; Steven R Cummings; Michael G Shlipak
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.